Dendritic cell-targeted tumor antigen delivery by glucosylated lipid nanoparticles for precision tumor immunotherapy

Key Points

• Enhanced delivery of tumor antigens is observed with glucosylated lipid nanoparticles, improving immune response.
• A notable increase in antigen uptake by dendritic cells demonstrates a promising approach for targeted therapy.
• The methodology includes dendritic cell-targeted delivery systems that utilize glucosylated lipid nanoparticles.
• This strategy may enable precision immunotherapy, though larger studies in diverse populations are needed.